Amrita Hospital Collaborates with International Society for Radiosurgery
Written by Susi, Arushi Sharma
Amrita Hospital has embarked on an exciting collaboration with the esteemed International Society for Radiosurgery, creating a powerful alliance that pushes the boundaries of medical excellence.
Amrita Hospital in Kochi has a radiosurgery course in collaboration with the International Stereotactic Radiosurgery Society. The goal of this course, "Advancements in Stereotactic Radiosurgery for Managing Benign Intracranial Tumors, Skull Base Tumors, and Abdominal Genitourinary and Gynecological Cancers," is to educate medical professionals about radiosurgery and stereotactic radiotherapy.
Radiosurgery is a patient-friendly therapy option due to its short treatment time. Studies at Amrita Hospital dispute the concept that shorter treatment periods make it cost-ineffective un India.
These studies show that radiosurgery has considerable benefits in terms of improving life quality and treatment outcomes.
Amrita Hospital's study of 138 brain metastasis patients found that 60% had managed brain lesions after 12 months, with 30% still doing so after 24 months. Only 9% of patients had radiation necrosis, confirming Stereotactic Radiosurgery (SRS) as a gold standard for Indian patients.
Amrita Hospitals’ three-day event, inaugurated by Dr. Prem Nair, aims to boost cancer and tumor treatment in India, featuring technologies like CyberKnife. Dr Mikhail Chernov, Chair of the ISRS Scientific Committee said “Amrita Hospitals’ approach to radiosurgery is structured.”
The event showcased experts like Professor Selcuk Peter from Turkey’s CyberKnife Centre, Professor Ian McCutcheon from MD Anderson Cancer Centre, and Dr. Rupesh Kotecha from Miami Cancer Centre, USA.
Interactive sessions and open forums fostered collaboration, advancing stereotactic radiosurgery and radiotherapy progress in India.
Professor Rakesh Jalali, Apollo Proton Cancer Centre, Chennai, said,
“Radiosurgeries are cost-effective in India.” He pointed to research showing equal importance, cost-effectiveness, and efficacy in Indian settings. Dr Prem Nair, Group Medical Director, Amrita Hospitals, said, “We are committed to delivering quality healthcare at an affordable cost.” He cited radiosurgery as a significant advancement.
Dr Debnarayan Dutta, Professor and Head of the Department of Radiation Oncology at Amrita Hospital, Kochi, said, “Indian and Western patient preferences are similar.”
Indian Society of Neuro-oncology (ISNO), Cochin Oncology Group (COG), Association of Radiation Oncology, India (AROI), Neurological Society of India (NSI), and Indian Society of Stereotactic and Functional Neurosurgery (ISSFN) endorsed his initiative.